Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 472041 - 472060 out of 476480 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EG02) everolimus (adm: O) | AFINITOR DISPERZ 5MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Breast Neoplasms;Pancreatic Neoplasms | NovartisPharmaceuticalsCorporation |
| USA | (L01EG02) everolimus (adm: O) | AFINITOR 7.5MG TAB | 1X28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Breast Neoplasms;Pancreatic Neoplasms | NovartisPharmaceuticalsCorporation |
| USA | (L01EG02) everolimus (adm: O) | AFINITOR 7.5MG TAB | 1X28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Breast Neoplasms;Pancreatic Neoplasms | NovartisPharmaceuticalsCorporation |
| USA | (L01EG04) sirolimus | HYFTOR 0.2% GEL,TOP | 10GM | Ex-factory price without vat |
$0-0 |
$0-0 |
Angiofibroma;Tuberous Sclerosis | NobelpharmaAmerica,LLC |
| USA | (L01EH01) lapatinib (adm: O) | TYKERB 250MG TAB | 150 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EH01) lapatinib (adm: O) | TYKERB 250MG TAB | 150 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EH03) tucatinib (adm: O) | TUKYSA 150MG TABLET | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Neoplasm Metastasis | SeagenInc. |
| USA | (L01EH03) tucatinib (adm: O) | TUKYSA 150MG TABLET | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Neoplasm Metastasis | SeagenInc. |
| USA | (L01EH03) tucatinib (adm: O) | TUKYSA 150MG TABLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Neoplasm Metastasis | SeagenInc. |
| USA | (L01EH03) tucatinib (adm: O) | TUKYSA 150MG TABLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Neoplasm Metastasis | SeagenInc. |
| USA | (L01EH03) tucatinib (adm: O) | TUKYSA 50MG TABLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Neoplasm Metastasis | SeagenInc. |
| USA | (L01EH03) tucatinib (adm: O) | TUKYSA 50MG TABLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Neoplasm Metastasis | SeagenInc. |
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI 10MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | IncyteCorporation |
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI 10MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | IncyteCorporation |
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI 15MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | IncyteCorporation |
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI 15MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | IncyteCorporation |
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI 20MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | IncyteCorporation |
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI 20MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | IncyteCorporation |
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI 25MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | IncyteCorporation |
| USA | (L01EJ01) ruxolitinib (adm: O) | JAKAFI 25MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | IncyteCorporation |
Pages
